Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
Soverini S, Colarossi S, Gnani A, Castagnetti F, Rosti G, Bosi C, Paolini S, Rondoni M, Piccaluga PP, Palandri F, Giannoulia P, Marzocchi G, Luatti S, Testoni N, Iacobucci I, Cilloni D, Saglio G, Baccarani M, Martinelli G.
Soverini S, et al. Among authors: testoni n.
Haematologica. 2007 Mar;92(3):401-4. doi: 10.3324/haematol.10822.
Haematologica. 2007.
PMID: 17339191
Free article.
Clinical Trial.